Key result
Evidence for a direct effect of coronary artery calcium scoring on hard cardiovascular outcomes is limited and does not fully explain the overestimation of ASCVD risk.
Answers are grounded in this paper and cite their sources.
This letter discusses the limitations of coronary artery calcium (CAC) scoring in explaining the overestimation of ASCVD risk by the AHA-ACC risk score.
Letters7 July 2015Calibration and Discrimination Among Multiple Cardiovascular Risk Scores in a Modern Multiethnic CohortAndrew P. DeFilippis, MD, MSc, Rebekah Young, PhD, and Michael J. Blaha, MD, MPHAndrew P. DeFilippis, MD, MScFrom University of Louisville, Louisville, Kentucky; University of Washington, Seattle, Washington; and Johns Hopkins Medicine Ciccarone Center for the Prevention of Heart Disease, Baltimore, Maryland.Search for more papers by this author, Rebekah Young, PhDFrom University of Louisville, Louisville, Kentucky; University of Washington, Seattle, Washington; and Johns Hopkins Medicine Ciccarone Center for the Prevention of Heart Disease, Baltimore, Maryland.Search for more papers by this author, and Michael J. Blaha, MD, MPHFrom University of Louisville, Louisville, Kentucky; University of Washington, Seattle, Washington; and Johns Hopkins Medicine Ciccarone Center for the Prevention of Heart Disease, Baltimore, Maryland.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/L15-5105-2 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:The study cited by Dr. Goff and colleagues (1) shows an association between CAC score and medication use, not an association with decreased events. As the authors acknowledge in the guideline (with the tepid grade IIb recommendation for CAC testing), evidence for a direct effect of CAC scoring on hard outcomes is limited (2). For CAC scoring to explain the overestimation of the risk for ASCVD, the reporting of CAC scores in MESA would have had to prevent almost one half of all ASCVD events predicted by the AHA-ACC-ASCVD risk score.The purpose of our sensitivity analysis was ...References1. Nasir K, McClelland RL, Blumenthal RS, Goff DC, Hoffmann U, Psaty BM, et al. Coronary artery calcium in relation to initiation and continuation of cardiovascular preventive medications: the Multi-Ethnic Study of Atherosclerosis (MESA). Circ Cardiovasc Qual Outcomes. 2010;3:228-35. [PMID: 20371760] doi:10.1161/CIRCOUTCOMES.109.893396 CrossrefMedlineGoogle Scholar2. Goff DC, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S49-73. [PMID: 24222018] doi:10.1161/01.cir.0000437741.48606.98 CrossrefMedlineGoogle Scholar3. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. 2007;49:69-75. [PMID: 17159087] CrossrefMedlineGoogle Scholar4. Qiuping G, Paulose-Ram R, Burt VL, Kit BK. Prescription cholesterol-lowering medication use in adults aged 40 and over: United States, 2003-2012. National Center for Health Statistics Data Brief no. 177. Hyattsville, Maryland: U.S. Department of Health and Human Services; 2014. Accessed at www.cdc.gov/nchs/data/databriefs/db177.htm#ref10 on 5 April 2015. Google Scholar5. Kavousi M, Leening MJ, Nanchen D, Greenland P, Graham IM, Steyerberg EW, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort. JAMA. 2014;311:1416-23. [PMID: 24681960] doi:10.1001/jama.2014.2632 CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: Andrew P. DeFilippis, MD, MSc; Rebekah Young, PhD; Michael J. Blaha, MD, MPHAffiliations: From University of Louisville, Louisville, Kentucky; University of Washington, Seattle, Washington; and Johns Hopkins Medicine Ciccarone Center for the Prevention of Heart Disease, Baltimore, Maryland.Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M14-1281. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoAn Analysis of Calibration and Discrimination Among Multiple Cardiovascular Risk Scores in a Modern Multiethnic Cohort Andrew P. DeFilippis , Rebekah Young , Christopher J. Carrubba , John W. McEvoy , Matthew J. Budoff , Roger S. Blumenthal , Richard A. Kronmal , Robyn L. McClelland , Khurram Nasir , and Michael J. Blaha Calibration and Discrimination Among Multiple Cardiovascular Risk Scores in a Modern Multiethnic Cohort David C. Goff Jr. , Ralph B. D'Agostino Sr. , Michael Pencina , and Donald M. Lloyd-Jones Metrics Cited byReporting and Perceptions of Breast Arterial Calcification on Mammography: A Survey of ACR RadiologistsDepartment of Veterans Affairs (VA) and U.S. Department of Defense (DoD) guidelines for management of dyslipidemia and cardiovascular disease risk reduction: Putting evidence in contextCeramide Scores Predict Cardiovascular Risk in the CommunityCoronary Artery Calcium Score for Personalization of Antihypertensive TherapyAssessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the ScienceCardiovascular risk algorithms in primary care: Results from the DETECT studyErectile Dysfunction and Subclinical Cardiovascular DiseaseExtravascular Contrast AgentsQuality and Equitable Health Care Gaps for WomenErectile Dysfunction: an Early Sign of Cardiovascular Disease 7 July 2015Volume 163, Issue 1Page: 68-69KeywordsAtherosclerotic cardiovascular diseaseCoronary artery calcificationDisclosureExercise therapyHealth surveysHypertensionMedical risk factorsNutritionPreventive medicineQualitative studies ePublished: 7 July 2015 Issue Published: 7 July 2015 Copyright & PermissionsCopyright © 2015 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
DeFilippis et al. (2015) conducted a letter in Cardiovascular risk. Coronary artery calcium (CAC) scoring was evaluated. Evidence for a direct effect of coronary artery calcium scoring on hard cardiovascular outcomes is limited and does not fully explain the overestimation of ASCVD risk.
Synapse has enriched 10 related papers. Consider them for comparative context: